<p>Veeva Systems（纽约证券交易所：VEEV - 获取免费报告）的目标股价在周一发布的一份研究报告中被瑞银集团的分析师从 185.00 美元上调至 215.00 美元，据 Benzinga 报道。该公司目前对这家科技公司的股票给予&#34;中性&#34;评级。瑞银集团的价格目标表明，该股的潜在上涨空间为 7.47%。</p>
<p>获取 <strong>Veeva Systems</strong> 警报：</p>
<ul>
<li>Veeva Systems：不断增加的 NDR 和其他胜利</li>
</ul>
<p>一些其他股票分析师最近也对该公司发布了报告。花旗集团将 Veeva Systems 的目标股价从 274.00 美元下调至 256.00 美元，并在 6 月 3 日星期一的一份报告中为该公司设定了&#34;买入&#34;评级。Guggenheim 将 Veeva Systems 的目标股价从 211.00 美元上调至 233.00 美元，并在 7 月 18 日星期四的一份研究报告中为该股设定了&#34;买入&#34;评级。加拿大皇家银行在 6 月 21 日星期五的一份研究报告中重申了对 Veeva Systems 的&#34;表现优异&#34;评级，并设定了 250.00 美元的目标股价。Truist Financial 将 Veeva Systems 的目标股价从 203.00 美元下调至 197.00 美元，并在 6 月 14 日星期五的一份报告中为该股设定了&#34;持有&#34;评级。最后，Stifel Nicolaus 将 Veeva Systems 的目标股价从 250.00 美元下调至 210.00 美元，并在 5 月 31 日星期五的一份研究报告中为该公司设定了&#34;买入&#34;评级。一位研究分析师对该股给予了卖出评级，六位分析师给予了持有评级，十六位分析师给予了买入评级。根据 MarketBeat 的数据，该股的共识评级为&#34;中度买入&#34;，共识目标股价为 229.64 美元。</p>
<p><strong>阅读我们关于 VEEV 的最新报告</strong></p>
<h2>Veeva Systems 股价上涨 0.4%</h2>
<ul>
<li>Veeva Systems 纽约证券交易所：VEEV 股票买入：生命科学云软件</li>
</ul>
<p>纽约证券交易所 VEEV 股票周一在午盘交易中上涨 0.81 美元，报价 200.06 美元。该股的交易量为 87,684 股，相比平均交易量 951,015 股。该公司的市值为 323.4 亿美元，市盈率为 59.01，PEG 比率为 1.93，贝塔系数为 0.80。该公司的 50 天移动平均价为 186.60 美元，200 天移动平均价为 202.28 美元。Veeva Systems 的 52 周最低价为 162.72 美元，52 周最高价为 236.90 美元。</p>
<p>Veeva Systems（纽约证券交易所：VEEV - 获取免费报告）上次公布季度业绩是在 5 月 30 日星期四。该科技公司在该季度报告中每股盈利为 1.03 美元，超过了 0.93 美元的共识预期 0.10 美元。Veeva Systems 的净资产收益率为 12.74%，净利润率为 22.34%。该公司在该季度的营收为 6.5035 亿美元，超过了分析师预期的 6.4173 亿美元。分析师们预计，Veeva Systems 在本财年将实现每股收益 4.19 美元。</p>
<h2>内部人士押注</h2>
<p>相关消息显示，高级副总裁 Jonathan Faddis 于 8 月 21 日星期三以每股 200.00 美元的均价出售了该公司股票的 2,353 股。这些股票的总价值为 470,600.00 美元。交易完成后，这位高级副总裁现在直接持有公司股票 9,035 股，价值约 1,807,000 美元。该交易已在美国证券交易委员会的一份备案文件中披露，可在此链接找到。此外，首席财务官 Timothy S. Cabral 于 6 月 7 日星期五以每股 184.33 美元的均价出售了 15,000 股股票。这些股票的总价值为 2,764,950.00 美元。交易完成后，首席财务官现在持有公司股票 8,391 股，价值 1,546,713.03 美元。该交易已在美国证券交易委员会的一份法律文件中披露，可在此链接找到。此外，高级副总裁 Jonathan Faddis 于 8 月 21 日星期三以每股 200.00 美元的均价出售了该公司股票的 2,353 股。这些股票的总价值为 470,600.00 美元。交易完成后，这位高级副总裁现在直接持有公司股票 9,035 股，价值约 1,807,000 美元。有公司内部人士持有的股份占公司股份的 10.50%。</p>
<h2>机构投资者对 Veeva Systems 的看法</h2>
<p>一些大型投资者最近增加或减少了他们在该公司的持股。Linscomb &amp; Williams Inc.在第四季度购入了 Veeva Systems 的新股，价值 1,479,000 美元。Robeco Institutional Asset Management B.V.在第四季度将其在 Veeva Systems 的持股增加了 32.7%。Robeco Institutional Asset Management B.V.现在拥有 206,220 股该科技公司股票，价值 365,000 美元，比上一季度增加了 50,868 股。APG Asset Management US Inc.在第四季度购入了 Veeva Systems 的新股，价值约 5,756,000 美元。Quantum Capital Management LLC NJ 在第四季度将其对 Veeva Systems 的持股增加了 9.8%。Quantum Capital Management LLC NJ 现在拥有 329,867 股该科技公司股票，价值 63,506,000 美元，比上一季度增加了 29,525 股。最后，Eisler Capital UK Ltd.在第四季度购入了 Veeva Systems 的新股，价值约 1,408,000 美元。公司股份的 88.20% 由对冲基金和其他机构投资者持有。</p>
<h2>Veeva Systems 公司简介（获取免费报告）</h2>
<p>Veeva Systems Inc 提供面向生命科学行业的基于云的软件。它提供 Veeva Commercial Cloud，一套软件和分析解决方案，如 Veeva 客户关系管理（CRM），可使制药和生物技术公司的客户面对员工能够使用；Veeva Vault PromoMats，一种端到端的内容和数字资产管理解决方案；Veeva Vault Medical，提供跨多个渠道和地理位置的医疗内容来源；Veeva Crossix，一款面向制药品牌的分析平台；Veeva OpenData，一种客户参考数据解决方案；Veeva Link，一种数据应用，允许链接生成实时情报；以及 Veeva Compass 包括美国的去标识化和纵向患者数据。</p>
<h2>参考资料</h2>
<ul>
<li>五只我们比 Veeva Systems 更喜欢的股票</li>
<li>解析医疗保健股票：为什么您可能想要投资</li>
<li>艾利莎的通往下一个万亿市值的道路</li>
<li>最活跃的股票：交易额与股票量</li>
<li>Mobileye Global：首席执行官对未来实力押注 1000 万美元</li>
<li>什么是股息冠军？如何投资冠军</li>
<li>3 家公司在降息之前增加股息支付</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZFRVY?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZFRVY"/></p>
<p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<p>→ 仅 3 次交易从 5000 美元增长到 130 万美元（来自知情者披露）(广告)</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04OTM0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04OTM0"/></p>
<h2>现在是否值得投资 1000 美元购买 Veeva Systems？</h2>
<p>在您考虑 Veeva Systems 之前，您会想听听这个。</p>
<p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉他们的客户现在购买，然后等待更广泛市场关注的股票... 而 Veeva Systems 不在名单上。</p>
<p>虽然 Veeva Systems 目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

VEEV

<p>瑞银集团（UBS Group）将 Veeva Systems（纽约证券交易所：VEEV）的目标股价从$X.00 上调至$Y.00，并维持 “中性” 评级。这一调整后的目标股价意味着相对于当前价格有 7.47% 的潜在上涨空间。各路分析师对 Veeva 的评级不一，共识为 1 个卖出、6 个持有和 16 个买入评级，反映出一个 “中等买入” 立场。此外，Veeva 最近的股票表现显示略微增长了 0.4%</p>

<p>Veeva Systems (NYSE:VEEV - Get Free Report) had its target price hoisted by analysts at UBS Group from $185.00 to $215.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a &#34;neutral&#34; rating on the technology company's stock. UBS Group's price objective would suggest a potential upside of 7.47% from the stock's current price.</p>
<div class="lb-trans"><p>Veeva Systems（纽约证券交易所：VEEV - 获取免费报告）的目标股价在周一发布的一份研究报告中被瑞银集团的分析师从 185.00 美元上调至 215.00 美元，据 Benzinga 报道。该公司目前对这家科技公司的股票给予&#34;中性&#34;评级。瑞银集团的价格目标表明，该股的潜在上涨空间为 7.47%。</p>
</div><p>Get <strong>Veeva Systems</strong> alerts:</p>
<ul>
<li>Veeva Systems: Increasing NDR and Other Wins</li>
</ul>
<div class="lb-trans"><p>获取 <strong>Veeva Systems</strong> 警报：</p>
<ul>
<li>Veeva Systems：不断增加的 NDR 和其他胜利</li>
</ul>
</div><p>A number of other equities analysts also recently issued reports on the company. Citigroup cut their price objective on Veeva Systems from $274.00 to $256.00 and set a &#34;buy&#34; rating for the company in a report on Monday, June 3rd. Guggenheim raised their target price on Veeva Systems from $211.00 to $233.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, July 18th. Royal Bank of Canada reaffirmed an &#34;outperform&#34; rating and set a $250.00 price target on shares of Veeva Systems in a research report on Friday, June 21st. Truist Financial dropped their price objective on shares of Veeva Systems from $203.00 to $197.00 and set a &#34;hold&#34; rating on the stock in a report on Friday, June 14th. Finally, Stifel Nicolaus cut their target price on shares of Veeva Systems from $250.00 to $210.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, May 31st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $229.64.</p>
<div class="lb-trans"><p>一些其他股票分析师最近也对该公司发布了报告。花旗集团将 Veeva Systems 的目标股价从 274.00 美元下调至 256.00 美元，并在 6 月 3 日星期一的一份报告中为该公司设定了&#34;买入&#34;评级。Guggenheim 将 Veeva Systems 的目标股价从 211.00 美元上调至 233.00 美元，并在 7 月 18 日星期四的一份研究报告中为该股设定了&#34;买入&#34;评级。加拿大皇家银行在 6 月 21 日星期五的一份研究报告中重申了对 Veeva Systems 的&#34;表现优异&#34;评级，并设定了 250.00 美元的目标股价。Truist Financial 将 Veeva Systems 的目标股价从 203.00 美元下调至 197.00 美元，并在 6 月 14 日星期五的一份报告中为该股设定了&#34;持有&#34;评级。最后，Stifel Nicolaus 将 Veeva Systems 的目标股价从 250.00 美元下调至 210.00 美元，并在 5 月 31 日星期五的一份研究报告中为该公司设定了&#34;买入&#34;评级。一位研究分析师对该股给予了卖出评级，六位分析师给予了持有评级，十六位分析师给予了买入评级。根据 MarketBeat 的数据，该股的共识评级为&#34;中度买入&#34;，共识目标股价为 229.64 美元。</p>
</div><p><strong>Read Our Latest Report on VEEV</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 VEEV 的最新报告</strong></p>
</div><h2>Veeva Systems Stock Up 0.4 %</h2>
<ul>
<li>Veeva Systems NYSE: VEEV Stock a Buy: Cloud Software for Life Sciences</li>
</ul>
<div class="lb-trans"><h2>Veeva Systems 股价上涨 0.4%</h2>
<ul>
<li>Veeva Systems 纽约证券交易所：VEEV 股票买入：生命科学云软件</li>
</ul>
</div><p>Shares of NYSE VEEV traded up $0.81 during midday trading on Monday, hitting $200.06. The stock had a trading volume of 87,684 shares, compared to its average volume of 951,015. The company has a market cap of $32.34 billion, a P/E ratio of 59.01, a PEG ratio of 1.93 and a beta of 0.80. The business's 50 day moving average is $186.60 and its 200-day moving average is $202.28. Veeva Systems has a 52 week low of $162.72 and a 52 week high of $236.90.</p>
<div class="lb-trans"><p>纽约证券交易所 VEEV 股票周一在午盘交易中上涨 0.81 美元，报价 200.06 美元。该股的交易量为 87,684 股，相比平均交易量 951,015 股。该公司的市值为 323.4 亿美元，市盈率为 59.01，PEG 比率为 1.93，贝塔系数为 0.80。该公司的 50 天移动平均价为 186.60 美元，200 天移动平均价为 202.28 美元。Veeva Systems 的 52 周最低价为 162.72 美元，52 周最高价为 236.90 美元。</p>
</div><p>Veeva Systems (NYSE:VEEV - Get Free Report) last posted its quarterly earnings results on Thursday, May 30th. The technology company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.10. Veeva Systems had a return on equity of 12.74% and a net margin of 22.34%. The firm had revenue of $650.35 million during the quarter, compared to analysts' expectations of $641.73 million. As a group, analysts expect that Veeva Systems will post 4.19 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Veeva Systems（纽约证券交易所：VEEV - 获取免费报告）上次公布季度业绩是在 5 月 30 日星期四。该科技公司在该季度报告中每股盈利为 1.03 美元，超过了 0.93 美元的共识预期 0.10 美元。Veeva Systems 的净资产收益率为 12.74%，净利润率为 22.34%。该公司在该季度的营收为 6.5035 亿美元，超过了分析师预期的 6.4173 亿美元。分析师们预计，Veeva Systems 在本财年将实现每股收益 4.19 美元。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士押注</h2>
</div><p>In related news, SVP Jonathan Faddis sold 2,353 shares of the firm's stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total value of $470,600.00. Following the transaction, the senior vice president now directly owns 9,035 shares of the company's stock, valued at approximately $1,807,000. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this link. In other Veeva Systems news, CFO Timothy S. Cabral sold 15,000 shares of the stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $184.33, for a total transaction of $2,764,950.00. Following the completion of the transaction, the chief financial officer now owns 8,391 shares of the company's stock, valued at $1,546,713.03. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Jonathan Faddis sold 2,353 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total value of $470,600.00. Following the completion of the sale, the senior vice president now directly owns 9,035 shares in the company, valued at approximately $1,807,000. The disclosure for this sale can be found here. 10.50% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>相关消息显示，高级副总裁 Jonathan Faddis 于 8 月 21 日星期三以每股 200.00 美元的均价出售了该公司股票的 2,353 股。这些股票的总价值为 470,600.00 美元。交易完成后，这位高级副总裁现在直接持有公司股票 9,035 股，价值约 1,807,000 美元。该交易已在美国证券交易委员会的一份备案文件中披露，可在此链接找到。此外，首席财务官 Timothy S. Cabral 于 6 月 7 日星期五以每股 184.33 美元的均价出售了 15,000 股股票。这些股票的总价值为 2,764,950.00 美元。交易完成后，首席财务官现在持有公司股票 8,391 股，价值 1,546,713.03 美元。该交易已在美国证券交易委员会的一份法律文件中披露，可在此链接找到。此外，高级副总裁 Jonathan Faddis 于 8 月 21 日星期三以每股 200.00 美元的均价出售了该公司股票的 2,353 股。这些股票的总价值为 470,600.00 美元。交易完成后，这位高级副总裁现在直接持有公司股票 9,035 股，价值约 1,807,000 美元。有公司内部人士持有的股份占公司股份的 10.50%。</p>
</div><h2>Institutional Investors Weigh In On Veeva Systems</h2>
<div class="lb-trans"><h2>机构投资者对 Veeva Systems 的看法</h2>
</div><p>Several large investors have recently added to or reduced their stakes in the business. Linscomb &amp; Williams Inc. purchased a new stake in shares of Veeva Systems during the fourth quarter worth $1,479,000. Robeco Institutional Asset Management B.V. grew its position in shares of Veeva Systems by 32.7% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 206,220 shares of the technology company's stock worth $365,000 after buying an additional 50,868 shares in the last quarter. APG Asset Management US Inc. purchased a new stake in shares of Veeva Systems during the fourth quarter worth approximately $5,756,000. Quantum Capital Management LLC NJ raised its holdings in Veeva Systems by 9.8% in the fourth quarter. Quantum Capital Management LLC NJ now owns 329,867 shares of the technology company's stock valued at $63,506,000 after acquiring an additional 29,525 shares in the last quarter. Finally, Eisler Capital UK Ltd. purchased a new position in Veeva Systems in the fourth quarter worth approximately $1,408,000. 88.20% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近增加或减少了他们在该公司的持股。Linscomb &amp; Williams Inc.在第四季度购入了 Veeva Systems 的新股，价值 1,479,000 美元。Robeco Institutional Asset Management B.V.在第四季度将其在 Veeva Systems 的持股增加了 32.7%。Robeco Institutional Asset Management B.V.现在拥有 206,220 股该科技公司股票，价值 365,000 美元，比上一季度增加了 50,868 股。APG Asset Management US Inc.在第四季度购入了 Veeva Systems 的新股，价值约 5,756,000 美元。Quantum Capital Management LLC NJ 在第四季度将其对 Veeva Systems 的持股增加了 9.8%。Quantum Capital Management LLC NJ 现在拥有 329,867 股该科技公司股票，价值 63,506,000 美元，比上一季度增加了 29,525 股。最后，Eisler Capital UK Ltd.在第四季度购入了 Veeva Systems 的新股，价值约 1,408,000 美元。公司股份的 88.20% 由对冲基金和其他机构投资者持有。</p>
</div><h2>Veeva Systems Company Profile (Get Free Report)</h2>
<div class="lb-trans"><h2>Veeva Systems 公司简介（获取免费报告）</h2>
</div><p>Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.</p>
<div class="lb-trans"><p>Veeva Systems Inc 提供面向生命科学行业的基于云的软件。它提供 Veeva Commercial Cloud，一套软件和分析解决方案，如 Veeva 客户关系管理（CRM），可使制药和生物技术公司的客户面对员工能够使用；Veeva Vault PromoMats，一种端到端的内容和数字资产管理解决方案；Veeva Vault Medical，提供跨多个渠道和地理位置的医疗内容来源；Veeva Crossix，一款面向制药品牌的分析平台；Veeva OpenData，一种客户参考数据解决方案；Veeva Link，一种数据应用，允许链接生成实时情报；以及 Veeva Compass 包括美国的去标识化和纵向患者数据。</p>
</div><h2>See Also</h2>
<ul>
<li>Five stocks we like better than Veeva Systems</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>Eli Lilly’s Path to the Next Trillion Market Capitalization</li>
<li>Most active stocks: Dollar volume vs share volume</li>
<li>Mobileye Global: CEO Makes $10 Million Bet on Future Strength</li>
<li>What Are Dividend Champions? How to Invest in the Champions</li>
<li>3 Stocks Increasing Dividend Payouts Ahead of Interest Rate Cuts</li>
</ul>
<div class="lb-trans"><h2>参考资料</h2>
<ul>
<li>五只我们比 Veeva Systems 更喜欢的股票</li>
<li>解析医疗保健股票：为什么您可能想要投资</li>
<li>艾利莎的通往下一个万亿市值的道路</li>
<li>最活跃的股票：交易额与股票量</li>
<li>Mobileye Global：首席执行官对未来实力押注 1000 万美元</li>
<li>什么是股息冠军？如何投资冠军</li>
<li>3 家公司在降息之前增加股息支付</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVZFRVY" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=VEEV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><p>→ $5k to $1.3m in just 3 trades (From Insiders Exposed)(Ad)</p>
<div class="lb-trans"><p>→ 仅 3 次交易从 5000 美元增长到 130 万美元（来自知情者披露）(广告)</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04OTM0" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8934&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Veeva Systems right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资 1000 美元购买 Veeva Systems？</h2>
</div><p>Before you consider Veeva Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Veeva Systems 之前，您会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉他们的客户现在购买，然后等待更广泛市场关注的股票... 而 Veeva Systems 不在名单上。</p>
</div><p>While Veeva Systems currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Veeva Systems 目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Veeva Systems（纽约证券交易所代码：VEEV）的目标价被上调至 215.00 美元